Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting
Brendan Farrell, Alexander L. Breeze
Biochemical Society Transactions (2018) Vol. 46, Iss. 6, pp. 1753-1770
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

FGF/FGFR signaling in health and disease
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 600
Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
Shuyan Dai, Zhan Zhou, Zhuchu Chen, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 614-614
Open Access | Times Cited: 246
Therapeutic Landscape for NAFLD in 2020
Brent A. Neuschwander‐Tetri
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1984-1998.e3
Closed Access | Times Cited: 168
Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities
Zihang Ling, Bin Cheng, Xiaoan Tao
International Journal of Cancer (2020) Vol. 148, Iss. 7, pp. 1548-1561
Open Access | Times Cited: 164
Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
Guihong Liu, Tao Chen, Zhenyu Ding, et al.
Cell Proliferation (2021) Vol. 54, Iss. 4
Open Access | Times Cited: 133
Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
Christopher Arter, Luke Trask, Sarah Ward, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 8, pp. 102247-102247
Open Access | Times Cited: 104
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Zhenyi Niu, Runsen Jin, Yan Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 95
Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis
Zhengchao Wang, Pengfei Zhu, Bokai Liao, et al.
Journal of Orthopaedic Surgery and Research (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 27
Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases
Luyao Shen, Yongsheng Li, Huakan Zhao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
The duality of human oncoproteins: drivers of cancer and congenital disorders
Pau Castel, Katherine A. Rauen, Frank McCormick
Nature reviews. Cancer (2020) Vol. 20, Iss. 7, pp. 383-397
Open Access | Times Cited: 66
Fibroblast Growth Factor Receptor Signaling in Skin Cancers
Małgorzata Czyż
Cells (2019) Vol. 8, Iss. 6, pp. 540-540
Open Access | Times Cited: 59
An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk
Sara Vázquez‐Sánchez, Jonay Poveda, José Alberto Navarro‐García, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 53
Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2
Guangyan Du, Jie Jiang, Qibiao Wu, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 29, pp. 15905-15911
Open Access | Times Cited: 43
Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
Chiara Francavilla, Ciara O’Brien
Open Biology (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 37
Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice
Léa Loisay, Davide Komla‐Ebri, Anne Morice, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 22
The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
Subhasmita Mahapatra, Nisha Amarnath Jonniya, Suman Koirala, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13509-13533
Closed Access | Times Cited: 17
Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma
Alessio Ardizzone, Sarah Adriana Scuderi, Dario Giuffrida, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3825-3825
Open Access | Times Cited: 44
Role of thyroid hormones in craniofacial development
Victoria D. Leitch, J. H. Duncan Bassett, Graham R. Williams
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 3, pp. 147-164
Closed Access | Times Cited: 41
Mechanical Stress Regulates Epithelial Tissue Integrity and Stiffness through the FGFR/Erk2 Signaling Pathway during Embryogenesis
Noriyuki Kinoshita, Yutaka Hashimoto, Naoko Yasue, et al.
Cell Reports (2020) Vol. 30, Iss. 11, pp. 3875-3888.e3
Open Access | Times Cited: 41
Galectins as modulators of receptor tyrosine kinases signaling in health and disease
Natalia Porębska, Marta Poźniak, Aleksandra Matynia, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 60, pp. 89-106
Open Access | Times Cited: 34
Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
Anderley Gordon, Edwina Johnston, David K. Lau, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1183-1196
Open Access | Times Cited: 26
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
Giovanni Brandi, Valeria Relli, Marzia Deserti, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis
Dominika Żukowska, Aleksandra Chorążewska, Krzysztof Ciura, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer
Lewis Au, J. Collin, John M. Mariadason
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1117-1117
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top